Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)

NCT05521984 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Pediatric Brain Tumor
Pediatric Solid Tumor

Interventions

DRUG: Dapagliflozin
DRUG: Carmustine
DRUG: Topotecan
DRUG: Cyclophosphamide

Sponsor

Washington University School of Medicine

Collaborators

[object Object]